CytomX Therapeutics Inc (CTMX)
1.63
+0.03
(+1.88%)
USD |
NASDAQ |
Apr 26, 10:42
CytomX Therapeutics Total Assets (Quarterly): 201.79M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 201.79M |
| September 30, 2023 | 221.17M |
| June 30, 2023 | 209.18M |
| March 31, 2023 | 234.63M |
| December 31, 2022 | 260.89M |
| September 30, 2022 | 226.49M |
| June 30, 2022 | 260.09M |
| March 31, 2022 | 296.82M |
| December 31, 2021 | 339.41M |
| September 30, 2021 | 371.23M |
| June 30, 2021 | 402.44M |
| March 31, 2021 | 434.16M |
| December 31, 2020 | 358.66M |
| September 30, 2020 | 375.18M |
| June 30, 2020 | 402.48M |
| March 31, 2020 | 436.66M |
| December 31, 2019 | 341.28M |
| September 30, 2019 | 372.54M |
| Date | Value |
|---|---|
| June 30, 2019 | 405.28M |
| March 31, 2019 | 444.51M |
| December 31, 2018 | 457.11M |
| September 30, 2018 | 482.73M |
| June 30, 2018 | 376.94M |
| March 31, 2018 | 376.46M |
| December 31, 2017 | 397.64M |
| September 30, 2017 | 387.04M |
| June 30, 2017 | 351.86M |
| March 31, 2017 | 177.88M |
| December 31, 2016 | 199.13M |
| September 30, 2016 | 192.88M |
| June 30, 2016 | 206.86M |
| March 31, 2016 | 191.95M |
| December 31, 2015 | 197.22M |
| September 30, 2015 | 124.78M |
| June 30, 2015 | 134.09M |
| December 31, 2014 | 73.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
201.79M
Minimum
Dec 2023
436.66M
Maximum
Mar 2020
323.71M
Average
341.28M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 33.08B |
| Sarepta Therapeutics Inc | 3.265B |
| Puma Biotechnology Inc | 230.53M |
| Ocular Therapeutix Inc | 252.06M |
| Bristol-Myers Squibb Co | 95.16B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 249.24M |
| Shareholders Equity (Quarterly) | -47.45M |
| Current Ratio | 1.173 |